UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Compare high yield versus low fee strategies in dividend investing to determine which factor more strongly influences long-term performance.
27,099 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Solana trades near the $92 level as Gemini AI weighs a path to $100. On-chain metrics flash caution, even as a bullis...
Ethereum sits around $2,170 as the scaling debate intensifies. Analysts warn that a fragmented L2 path and security c...
Silver markets tighten as COMEX inventories shrink and the pricing curve tightens. Traders ask how long the exchange ...
Bank of America has reinstated its coverage on ServiceNow with a Buy rating, citing the platform's pivotal role in AI...
A lawyer-turned-DJ builds shipping-container sports clubs in refugee camps, blending grant funding with revenue from ...
Blockchain investigator ZachXBT raises red flags about Rain Protocol, citing on-chain patterns and a lofty market cap...
A top cloud platform just posted a record-breaking quarter as Micron pulls back, prompting investors to shift toward ...
As summers heat up, teen summer employment headed for the weakest season since 1948, with job openings shrinking and ...
XRP sits near the $1 level, slipping 9% over the past week and 52% year over year. An analyst says the move could for...
Microsoft shares have fallen sharply this year, yet bulls argue that cloud growth and AI initiatives underpin a resil...
Trump floated an Australia-style retirement account as a supplement to Social Security. This report breaks down who c...